LBA50 - Mechanisms of acquired resistance to first-line osimertinib: preliminary data from the phase III…
jwood@krftwrk.caNovember 14, 2018
ESMO 2016. LBA8_PR. KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced…
jwood@krftwrk.caNovember 9, 2016
News in Lung Cancer ASCO 2015. Abstract 9001. Epidermal growth factor receptor (EGFR) genotyping of…
jwood@krftwrk.caJune 29, 2016
